Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Antiviral agent 35

Catalog No. T79567Cas No. 2760972-52-7

Antiviral agent 35 (compound 4d) is a potent oral inhibitor of the influenza virus, targeting early stages of viral replication. It suppresses influenza-induced ROS accumulation, autophagy, apoptosis, and the inflammatory response mediated by the RIG-1 pathway in a mouse model of pulmonary infection. Its cytotoxicity is minimal in MDCK cells, with a CC50 greater than 800 μM, and it has anti-H1N1 (A/Weiss/43) activity with an EC50 of 2.28 μM [1].

Antiviral agent 35

Antiviral agent 35

Catalog No. T79567Cas No. 2760972-52-7
Antiviral agent 35 (compound 4d) is a potent oral inhibitor of the influenza virus, targeting early stages of viral replication. It suppresses influenza-induced ROS accumulation, autophagy, apoptosis, and the inflammatory response mediated by the RIG-1 pathway in a mouse model of pulmonary infection. Its cytotoxicity is minimal in MDCK cells, with a CC50 greater than 800 μM, and it has anti-H1N1 (A/Weiss/43) activity with an EC50 of 2.28 μM [1].
Pack SizePriceAvailabilityQuantity
5 mgInquiry8-10 weeks
50 mgInquiry8-10 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Antiviral agent 35 (compound 4d) is a potent oral inhibitor of the influenza virus, targeting early stages of viral replication. It suppresses influenza-induced ROS accumulation, autophagy, apoptosis, and the inflammatory response mediated by the RIG-1 pathway in a mouse model of pulmonary infection. Its cytotoxicity is minimal in MDCK cells, with a CC50 greater than 800 μM, and it has anti-H1N1 (A/Weiss/43) activity with an EC50 of 2.28 μM [1].
In vitro
Antiviral agent 35 (compound 4d), at concentrations of 25 μM and 50 μM over a period of 24 to 72 hours, inhibits the replication of the influenza virus in MDCK cells [1].
In vivo
Antiviral agent 35 (compound 4d), administered to mice orally via gavage at dosages of 25, 50, and 100 mg/kg/day on days 2, 4, and 6 post-H1N1 infection, reduced pulmonary inflammation [1].
Chemical Properties
Molecular Weight418.47
FormulaC23H18N2O4S
Cas No.2760972-52-7
Storage & Solubility Information
StorageShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Antiviral agent 35 | purchase Antiviral agent 35 | Antiviral agent 35 cost | order Antiviral agent 35 | Antiviral agent 35 chemical structure | Antiviral agent 35 in vivo | Antiviral agent 35 in vitro | Antiviral agent 35 formula | Antiviral agent 35 molecular weight